Belinostat loaded lipid–polymer hybrid nanoparticulate delivery system for breast cancer: improved pharmacokinetics and biodistribution in a tumor model
Article in Journal of Materials Chemistry B (November 2023)
The most recent citing publications are shown below. View all 39 publications that cite this research output on Dimensions.
Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer
Article in Cellular Oncology (November 2023)
CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines
Article in Scientific Reports (October 2023)